SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave ($CRWV) is trending as investors brace for earnings amid mixed sentiment. While some bulls express confidence in the AI infrastructure play, citing strong backlog and key partnerships, others are wary of high debt and recent insider selling. Community discussions revolve around the potential impact of Q4 guidance and comparisons to sector peers like $NBIS.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending due to positive reactions to earnings and the acquisition of Ask Sage, with investors focusing on the potential for government contracts and long-term growth. The community is discussing the company's prospects as a "mini PLTR" and anticipating a rise in stock price, while also debating the impact of potential dilution.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. TeraWulf will generate domestically produced bitcoin powered by nuclear, hydro and solar energy. The company was founded by Paul Prager and Nazar Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is trending as investors digest recent earnings and a strategic pivot towards High-Performance Computing (HPC) and AI hosting, especially the Abernathy Joint Venture backed by Google. Community chatter highlights confidence in management's execution and future potential, with some anticipating analyst upgrades and new contracts before year-end. Despite mixed reactions to earnings, TeraWulf's AI infrastructure and partnerships are central to ongoing discussions.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

CAPR is trending as investors await top-line data from its Phase 3 HOPE-3 trial for Duchenne muscular dystrophy, with the release expected in the coming weeks. Community sentiment is positive, particularly around the CEO's confidence and the potential for the drug to address a critical unmet need, while some analysts emphasize the importance of both cardiac and skeletal muscle function data for approval.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending as investors digest recent Q3 earnings and look ahead to key milestones. While some express concerns about launch timelines and cash burn, the community is also highlighting significant government contracts and revenue commitments. Discussions revolve around the company's potential for future growth and its ability to execute its satellite deployment plans.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending as investors digest recent earnings, which included a revenue beat and record gross margins, alongside news of the Neutron rocket program's progress and a Q1 2026 arrival at Launch Complex 3. While some express concern over the Neutron launch potentially being pushed to late 2026, many bulls see this as a buying opportunity, citing the company's strong existing revenue and significant backlog of launch contracts. The community is actively debating the long-term impact of the Neutron update and its potential for a gamma squeeze given a substantial short interest.

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

Cleanspark (CLSK) is trending amid discussions about a recent convertible note offering and its potential implications for the company's AI strategy. While some investors express concerns about dilution and debt, others view the offering as a bullish move to fund expansion into AI data centers and execute share buybacks. The community is actively debating whether the financing will ultimately benefit the company and drive future growth in the competitive mining sector.

Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. The company was founded by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye in 2011 and is headquartered in Boston, MA.

Galecto Inc

Galecto Inc. is trending due to a significant price surge, fueled by the completion of its acquisition of Damora Therapeutics and a substantial funding round. Community discussions revolve around the potential for a short squeeze, given the stock's low float and high cost to borrow, with some traders eyeing ambitious price targets. Comparisons to other high-flying stocks and potential catalysts related to their pipeline are also being actively discussed.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is trending downwards amidst concerns about its high valuation relative to revenue, especially after a recent earnings report revealed a GAAP net loss. Community members are discussing whether the company can justify its valuation given its revenue and comparing it unfavorably to competitors like D-Wave, while some suggest an offering may be imminent. The stock's movement is also being watched in relation to the broader quantum computing sector and potential government funding.

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Anavex Life Sciences Corporation

Anavex Life Sciences Corp

AVXL is trending as investors eagerly await the CHMP's opinion on Blarcamesine, its Alzheimer's drug, with discussions focused on the potential for conditional approval and partnership opportunities. Community members are debating the likelihood of a positive outcome and the impact of short sellers, while also analyzing the upcoming oral explanation with the EMA committee. Many express hope for a breakthrough treatment option given the limited choices currently available for Alzheimer's patients.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
